Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Get Free Report) insider Patrick Burnett sold 955 shares of the business’s stock in a transaction that occurred on Monday, August 3rd. Patrick Burnett also recently made the following trade(s):Get Arcutis Biotherapeutics alerts:On Monday, May 11th, Patrick Burnett sold 222 shares of Arcutis Biotherapeutics stock. Arcutis Biotherapeutics Stock Up 4.1%ARQT opened at $27.10 on Thursday. Key Arcutis Biotherapeutics NewsArcutis Biotherapeutics ( NASDAQ:ARQT Get Free Report ) last announced its quarterly earnings data on Wednesday, August 5th. Featured ArticlesReceive News & Ratings for Arcutis Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcutis Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.